{"id":"https://openalex.org/W2000826124","doi":"https://doi.org/10.1111/j.1600-0404.1973.tb02285.x","title":"KLINISCHE ERFAHRUNGEN MIT CLONAZEPAM UNTER BESONDERER BER\u00dcCKSICHTIGUNG PSYCHOMOTORISCHER ANF\u00c4LLE","display_name":"KLINISCHE ERFAHRUNGEN MIT CLONAZEPAM UNTER BESONDERER BER\u00dcCKSICHTIGUNG PSYCHOMOTORISCHER ANF\u00c4LLE","publication_year":2009,"publication_date":"2009-01-29","ids":{"openalex":"https://openalex.org/W2000826124","doi":"https://doi.org/10.1111/j.1600-0404.1973.tb02285.x","mag":"2000826124","pmid":"https://pubmed.ncbi.nlm.nih.gov/4586920"},"language":"de","primary_location":{"id":"doi:10.1111/j.1600-0404.1973.tb02285.x","doi":"https://doi.org/10.1111/j.1600-0404.1973.tb02285.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1600-0404.1973.tb02285.x","pdf_url":null,"source":{"id":"https://openalex.org/S66034498","display_name":"Acta Neurologica Scandinavica","issn_l":"0001-6314","issn":["0001-6314","1600-0404"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Neurologica Scandinavica","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5027306063","display_name":"Hermes Andreas Kick","orcid":"https://orcid.org/0000-0002-3843-1784","observed_orcids":["https://orcid.org/0000-0002-3843-1784"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H. Kick","raw_affiliation_strings":["Anstalt Bethel, Bielefeld, Deutschland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Anstalt Bethel, Bielefeld, Deutschland","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111491548","display_name":"Rudolf Dreyer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"R. Dreyer","raw_affiliation_strings":["Anstalt Bethel, Bielefeld, Deutschland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Anstalt Bethel, Bielefeld, Deutschland","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5111491548"],"corresponding_institution_ids":[],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":8,"citation_normalized_percentile":{"value":0.12729697,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"49","issue":"S53","first_page":"54","last_page":"59"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12229","display_name":"Pharmacological Effects and Toxicity Studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12267","display_name":"Diet and metabolism studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/clonazepam","display_name":"clonazepam","score":1.0},{"id":"https://openalex.org/keywords/psychomotor-epilepsy","display_name":"psychomotor epilepsy","score":0.9670000076293945},{"id":"https://openalex.org/keywords/drug-resistant-epilepsy","display_name":"drug-resistant epilepsy","score":0.7979999780654907},{"id":"https://openalex.org/keywords/lennox-gastaut-syndrome","display_name":"Lennox-Gastaut syndrome","score":0.8349999785423279},{"id":"https://openalex.org/keywords/status-epilepticus","display_name":"status epilepticus","score":0.9200000166893005},{"id":"https://openalex.org/keywords/generalized-tonic-clonic-seizures","display_name":"generalized tonic-clonic seizures","score":0.8040000200271606},{"id":"https://openalex.org/keywords/diazepam","display_name":"diazepam","score":0.7879999876022339},{"id":"https://openalex.org/keywords/phenytoin","display_name":"phenytoin","score":0.9760000109672546},{"id":"https://openalex.org/keywords/antiepileptic-drug-efficacy","display_name":"antiepileptic drug efficacy","score":0.7369999885559082},{"id":"https://openalex.org/keywords/adverse-effects","display_name":"adverse effects","score":0.5910000205039978}],"concepts":[{"id":"https://openalex.org/C2779426884","wikidata":"https://www.wikidata.org/wiki/Q407988","display_name":"Clonazepam","level":2,"score":0.9624334573745728},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7382063865661621},{"id":"https://openalex.org/C2777341932","wikidata":"https://www.wikidata.org/wiki/Q980709","display_name":"Status epilepticus","level":3,"score":0.6306891441345215},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.5902907848358154},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.5825782418251038},{"id":"https://openalex.org/C3019728164","wikidata":"https://www.wikidata.org/wiki/Q1406803","display_name":"Grand mal","level":3,"score":0.5786197781562805},{"id":"https://openalex.org/C2776175493","wikidata":"https://www.wikidata.org/wiki/Q210402","display_name":"Diazepam","level":2,"score":0.541827917098999},{"id":"https://openalex.org/C2778337148","wikidata":"https://www.wikidata.org/wiki/Q410400","display_name":"Phenytoin","level":3,"score":0.5043855905532837},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.37570178508758545},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.05344533920288086}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001570","descriptor_name":"Benzodiazepinones","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D001570","descriptor_name":"Benzodiazepinones","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001570","descriptor_name":"Benzodiazepinones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002722","descriptor_name":"Chlorobenzenes","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002722","descriptor_name":"Chlorobenzenes","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D002722","descriptor_name":"Chlorobenzenes","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004341","descriptor_name":"Drug Evaluation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004569","descriptor_name":"Electroencephalography","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004827","descriptor_name":"Epilepsy","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D004833","descriptor_name":"Epilepsy, Temporal Lobe","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005221","descriptor_name":"Fatigue","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007275","descriptor_name":"Injections, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009207","descriptor_name":"Myoclonus","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009574","descriptor_name":"Nitro Compounds","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D009574","descriptor_name":"Nitro Compounds","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D009574","descriptor_name":"Nitro Compounds","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1111/j.1600-0404.1973.tb02285.x","doi":"https://doi.org/10.1111/j.1600-0404.1973.tb02285.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1600-0404.1973.tb02285.x","pdf_url":null,"source":{"id":"https://openalex.org/S66034498","display_name":"Acta Neurologica Scandinavica","issn_l":"0001-6314","issn":["0001-6314","1600-0404"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Neurologica Scandinavica","raw_type":"journal-article"},{"id":"pmid:4586920","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/4586920","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta neurologica Scandinavica. Supplementum","raw_type":"Clinical Trial"},{"id":"mag:2402852498","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/4586920","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9922999739646912,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2139160579","https://openalex.org/W2411562174","https://openalex.org/W2024239690","https://openalex.org/W2052531931","https://openalex.org/W2402852498","https://openalex.org/W1983725340","https://openalex.org/W2070939255","https://openalex.org/W2079612969","https://openalex.org/W2053390336","https://openalex.org/W2089334613"],"abstract_inverted_index":{"The":[0,33,64,136,156,214,252],"authors":[1,121,253],"carried":[2,123],"out":[3,109,124],"this":[4,84,217],"study":[5,229],"on":[6,126],"34":[7,90],"patients":[8,26,39,91,98,113,167,225,258],"with":[9,161,176,259],"various":[10,177,260],"types":[11,178,261],"of":[12,24,36,46,57,67,69,74,89,110,150,158,171,179,194,216,241,262],"psychomotor":[13,263],"epilepsy":[14],"(idiopathic":[15],"or":[16,106],"symptomatic)":[17],"resistant":[18],"to":[19,59,206,233],"customary":[20,266],"treatment.":[21],"A":[22,186],"few":[23,202],"these":[25,96,111],"also":[27,122],"occasionally":[28],"had":[29,114,237],"grand":[30],"mal":[31],"seizures.":[32,118],"average":[34,153],"age":[35],"the":[37,44,72,81,120,151,169,192,224,228],"treated":[38],"was":[40,53,71,189],"26":[41],"years,":[42],"and":[43,173,212,236,248],"duration":[45],"disease":[47],"17":[48],"years.":[49],"Clonazepam":[50,204],"(Ro":[51],"5-4023)":[52],"administered":[54],"at":[55],"doses":[56,154],"2":[58],"12":[60,92,97],"mg":[61],"per":[62,78],"day.":[63],"main":[65],"criterion":[66],"success":[68],"treatment":[70,160,235],"reduction":[73],"seizures":[75,134],"by":[76,145],"50":[77],"cent":[79],"in":[80,257],"first":[82],"month,":[83],"improvement":[85,102],"being":[86],"maintained.":[87],"Out":[88],"showed":[93,100],"improvement.":[94],"Of":[95],"7":[99,112],"remarkable":[101],"for":[103,227],"5":[104],"months":[105],"more,":[107],"3":[108],"no":[115],"further":[116],"epileptic":[117],"Furthermore,":[119],"investigations":[125],"20":[127],"children":[128],"mainly":[129,231],"suffering":[130],"from":[131],"myoclonic":[132],"astatic":[133],"(Lennox-syndrome).":[135],"results":[137,157,197,215],"were":[138,163,182,198,230,245],"not":[139,250],"so":[140],"good":[141,196,222],"as":[142,223],"those":[143],"obtained":[144,199],"previous":[146],"investigators,":[147],"possibly":[148],"because":[149],"below":[152],"used.":[155],"intravenous":[159],"clona-zepam":[162],"highly":[164],"satisfactory.":[165],"Six":[166],"between":[168],"ages":[170],"8":[172],"62":[174],"years":[175],"status":[180],"epilepticus":[181],"given":[183],"clonazepam":[184,256],"intravenously.":[185],"continuous":[187],"EEG-control":[188],"recorded.":[190],"In":[191],"majority":[193],"cases":[195],"within":[200],"a":[201,238],"minutes.":[203],"proved":[205],"be":[207,220],"more":[208],"effective":[209],"than":[210],"diazepam":[211],"phenytoin.":[213],"investigation":[218],"can":[219],"considered":[221],"chosen":[226],"therapy-resistant":[232],"standard":[234],"severe":[239],"type":[240],"epilepsy.":[242],"Side":[243],"effects":[244],"minimal,":[246],"mild":[247],"did":[249],"persist.":[251],"suggest":[254],"using":[255],"epilepsy,":[264],"where":[265],"therapy":[267],"has":[268],"failed.":[269]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}